Sleep problems in depression: How do they impact treatment and recovery?

International Journal of Psychiatry in Clinical Practice

Volumn 10, Issue SUPPL. 1, 2006, Pages 38-44

  Wade, Alan G ^a  

^a CPS Research   (United Kingdom)

Author keywords

Depression; Insomnia; Sleep; Treatment

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIMETABOLITE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRONCHODILATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CENTRAL STIMULANT AGENT; CITALOPRAM; CORTICOSTEROID; CORTICOTROPIN; DECONGESTIVE AGENT; DIURETIC AGENT; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; HYPNOTIC AGENT; LEVODOPA; METHYLDOPA; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; NORADRENALIN UPTAKE INHIBITOR; ORAL CONTRACEPTIVE AGENT; PAROXETINE; PHENYTOIN; QUINIDINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VENLAFAXINE; ZOLPIDEM;

BEHAVIOR THERAPY; CHRONIC DISEASE; CLINICAL TRIAL; COGNITIVE DEFECT; COMORBIDITY; CONFERENCE PAPER; DAYTIME SOMNOLENCE; DEPRESSION; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG RECEPTOR BINDING; HEALTH SURVEY; HUMAN; INSOMNIA; OBSERVATIONAL STUDY; OUTPATIENT DEPARTMENT; PATIENT COMPLIANCE; POLYSOMNOGRAPHY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PSYCHOMOTOR DISORDER; REM SLEEP; RISK ASSESSMENT; RISK FACTOR; SEDATION; SLEEP DISORDER; SLEEP PATTERN; TREATMENT OUTCOME;

EID: 33645774679     PISSN: 13651501     EISSN: None     Source Type: Journal    
DOI: 10.1080/13651500600552594     Document Type: Conference Paper

References (34)

1. Jessop EG. Sleep. J Public Health Med 2001;23:89-90.
2. Walsh JK. Clinical and socioeconomic correlates of insomnia. J Clin Psychiatry 2004;65(Suppl 8):13-9.
3. Ohayon MM, Lemoine P. Sleep and insomnia markers in the general population [in French]. Encephale 2004;30:135-40.
4. Chevalier H, Los F, Boichut D, et al. Evaluation of severe insomnia in the general population: Results of a European multinational survey. J Psychopharmacology 1999;13(Suppl 1):S21-4.
5. Wilson S, Argyropoulos S. Antidepressants and sleep: a qualitative review of the literature. Drugs 2005;65:927-47.
6. Jindal RD, Thase ME. Treatment of insomnia associated with clinical depression. Sleep Med Rev 2004;8:19-30.
7. Breslau N, Roth T, Rosenthal L, Andreski P. Daytime sleepiness: An epidemiological study of young adults. Am J Public Health 1997;87:1649-53.
8. American Psychiatric Association. Diagnostic and statistical manual of mental disorders - text revision, 4th ed. Washington, DC: American Psychiatric Publishing Inc.; 2000.
9. Nowell PD, Buysse DJ. Treatment of insomnia in patients with mood disorders. Depress Anxiety 2001;14:7-18.
10. Jindal RD, Buysse DJ, Thase ME. Maintenance treatment of insomnia: What can we learn from the depression literature? Am J Psychiatry 2004;161:19-24.
11. Mellinger GD, Balter MB, Uhlenhuth EH. Insomnia and its treatment. Prevalence and correlates. Arch Gen Psychiatry 1985;42:225-32.
12. Üstün TB, Privert M, Lecrubier Y, et al. Form, frequency and burden of sleep problems in general health care: A report from the WHO Collaborative Study on Psychological Problems in General Health Care. Eur Psychiatry 1996;11(Suppl 1):5s-10s.
13. Thase ME. Correlates and consequences of chronic insomnia. Gen Hosp Psychiatry 2005;27:100-12.
14. Czeisler CA, Winkelman JW, Richardson GS. Sleep disorders. In: Harrison's Principles of Intenal Medicine. McGraw-Hill: New York; 2005.
15. Simon GE, VonKorff M. Prevalence, burden, and treatment of insomnia in primary care. Am J Psychiatry 1997;154:1417-23.
16. Horne JA, Reyner LA. Sleep related vehicle accidents. BMJ 1995;310:5657.
17. Ohayon MM, Lader MH. Use of psychotropic medication in the general population of France, Germany, Italy, and the United Kingdom. J Clin Psychiatry 2002;63:817-25.
18. Tylee A, Gastpar M, Lepine JP, Mendlewicz J. Identification of depressed patient types in the community and their treatment needs: Findings from the DEPRES II (Depression Research in European Society II) survey. DEPRES Steering Committee. Int Clin Psychopharmacol 1999;14:153-65.
19. Tylee A, Gastpar M, Lepine JP, Mendlewicz J. DEPRES II (Depression Research in European Society II): a patient survey of the symptoms, disability and current management of depression in the community. DEPRES Steering Committee. Int Clin Psychopharmacol 1999;14:139-51.
20. Lader M, Andersen HF, Baekdal T. The effect of escitalopram on sleep problems in depressed patients. Hum Psychopharmacol 2005;20:349-54.
21. Ford DE, Cooper-Patrick L. Sleep disturbances and mood disorders: An epidemiologic perspective. Depress Anxiety 2001;14:3-6.
22. Jindal RD, Friedman ES, Berman SR. Effects of sertraline on sleep architecture in patients with depression. J Clin Psychopharmacol 2003;23:540-8.
23. Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? J Am Med Assoc 1989;262:1479-84.
24. Livingston G, Blizard B, Mann A. Does sleep disturbance predict depression in elderly people? A study in inner London. Br J Gen Pract 1993;43:445-8.
25. Chang PP, Ford DE, Mead LA, et al. Insomnia in young men and subsequent depression. The Johns Hopkins Precursors Study. Am J Epidemiol 1997;146:105-14.
26. Winokur A, Gary KA, Rodner S, et al. Depression, sleep physiology, and antidepressant drugs. Depress Anxiety 2001;14:19-28.
27. Rijnbeek B, de Visser SJ, Franson KL, et al. REM sleep effects as a biomarker for the effects of antidepressants in healthy volunteers. J Psychopharmacol 2003;17:196-203.
28. Thase ME. Antidepressant treatment of the depressed patient with insomnia. J Clin Psychiatry 1999;60(Suppl 17):28-31.
29. Manber R, Blasey C, Arnow B, et al. Assessing insomnia severity in depression: Comparison of depression rating scales and sleep diaries. J Psychiatr Res 2005;39:481-8.
30. Kupfer DJ. Pathophysiology and management of insomnia during depression. Ann Clin Psychiatry 1999;11:267-76.
31. Smith MT, Perlis ML, Park A, et al. Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia. Am J Psychiatry 2002;159:5-11.
32. Benca RM. Diagnosis and treatment of chronic insomnia: A review. Psychiatr Serv 2005;56:332-43.
33. Asnis GM, Chakraburtty A, DuBoff EA, et al. Zolpidem for persistent insomnia in SSRI-treated depressed patients. J Clin Psychiatry 1999;60:668-76.
34. Owens MJ, Knight DL, Nemeroff CB. Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine. Biol Psychiatry 2001;50:345-50.